Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

17 June 2008

Liver transplantation for fulminant Wilson’s disease in children

Małgorzata Markiewicz-Kijewska, Marek Szymczak, Hor Ismail, Sylwester Prokurat, Joanna Teisseyre, Piotr Socha, Irena Jankowska, Anna Chyżyńska, Piotr Kaliciński, Marek Migdał

Ann Transplant 2008; 13(2): 28-31 :: ID: 858103


Background: Fulminant Wilson’s disease (FWD) is rare and fatal condition in children unless liver transplantation is performed, however introduction of new technologies could change this poor prognosis. The aim of our study was retrospective analysis of clinical course, treatment and outcome of children with FWD treated in our institution.
Material/Methods: Between 1999–2007 we’ve treated in our hospital 13 patients with mean age of 15.5 yrs with FWD. We performed retrospective analysis of clinical course, biochemical parameters, MELD/PELD score, Wilson score and Kings’-College criteria for LTx in acute liver failure in all these patients. Type of treatment and final outcome were analyzed, as well as qualification for transplantation was reevaluated in each case in accordance to pathological examination of explanted during transplantation livers.
Results: The initial symptoms of FWD were typically weakness, abdominal pain and developing later after 5–60 days (mean 20 days), jaundice. Eleven patients developed neurological symptoms with coma lasting for 2–11 days before transplantation or death. Maximal serum bilirubin concentration ranged between 4.5–71.6 mg% (mean 42.24 mg%), INR 2.9–10.0 (mean 5.4). MELD/PELD score was between 21–58 (mean 38), 10 patients fulfilled general King’s-College criteria for transplantation in acute liver failure. Wilson’s index ranged between 11 and 17 points (mean 13 points). In 11 children urgent liver transplantation (LTx) was performed, 1 child recovered on albumin dialysis and chelating treatment, 1 child died shortly after very late referral to our center. Actual follow-up of living patients is 0.36–7.43 years (mean 2.57 yrs), all are doing well with good liver function.
Conclusions: FWD lead to death in almost all pediatric patients if LTx can not be performed, however early introduction of albumin dialysis (MARS) and chelating therapy allowed for survival without transplantation in single patient. It seems also that MARS therapy allows for at least prolongation of waiting time for LTx. Wilson’s was slightly better predictor of need for LTx in our patients than classical Kings’-College criteria.

Keywords: fulminant Wilson’s disease , urgent liver transplantation , Wilson’s index

Add Comment 0 Comments

348 19

In Press

06 Jun 2023 : Original article  

A 15-Year Retrospective Study of Supportive Extracorporeal Therapies Including Plasma Exchange and Continuo...

Ann Transplant In Press; DOI: 10.12659/AOT.939745  

02 Jun 2023 : Original article  

Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria a...

Ann Transplant In Press; DOI: 10.12659/AOT.939890  

10 May 2023 : Original article  

Incidence of Thromboembolic Complications Following Kidney Transplantation with Short and Extended Aspirin ...

Ann Transplant In Press; DOI: 10.12659/AOT.939143  

Most Viewed Current Articles

24 Aug 2021 : Review article  

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358